Are dopamine, norepinephrine, and serotonin precursors of biologically reactive intermediates involved in the pathogenesis of neurodegenerative brain disorders?

[1]  H. Li,et al.  Oxidative metabolites of 5-S-cysteinylnorepinephrine are irreversible inhibitors of mitochondrial complex I and the alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase complexes: possible implications for neurodegenerative brain disorders. , 2000, Chemical research in toxicology.

[2]  G. Gudelsky,et al.  Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration. , 2000, European journal of pharmacology.

[3]  M. Guertin,et al.  Hydroxyl Radical Production in the Cortex and Striatum in a Rat Model of Focal Cerebral Ischemia , 2000, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[4]  M. Cynader,et al.  Astrocytes Provide Cysteine to Neurons by Releasing Glutathione , 2000, Journal of neurochemistry.

[5]  J. Blass,et al.  Inherent Abnormalities in Energy Metabolism in Alzheimer Disease: Interaction with Cerebrovascular Compromise , 2000, Annals of the New York Academy of Sciences.

[6]  Hua Yang,et al.  A theoretical description of microdialysis with mass transport coupled to chemical events. , 2000, Analytical chemistry.

[7]  C. L. Wienburg,et al.  Organochlorine insecticides in substantia nigra in Parkinson's disease. , 2000, Journal of toxicology and environmental health. Part A.

[8]  G. Zeevalk,et al.  NMDA Receptors Modulate Dopamine Loss due to Energy Impairment in the Substantia Nigra but not Striatum , 2000, Experimental Neurology.

[9]  R. Wightman,et al.  Real-time amperometric measurements of zeptomole quantities of dopamine released from neurons. , 2000, Analytical chemistry.

[10]  K. Mohanakumar,et al.  In vivo hydroxyl radical generation in the striatum following systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice , 2000, Brain Research.

[11]  D. Kuhn,et al.  Peroxynitrite Inactivation of Tyrosine Hydroxylase: Mediation by Sulfhydryl Oxidation, not Tyrosine Nitration , 1999, The Journal of Neuroscience.

[12]  K. McNaught,et al.  Altered Glial Function Causes Neuronal Death and Increases Neuronal Susceptibility to 1‐Methyl‐4‐Phenylpyridinium‐ and 6‐Hydroxydopamine‐Induced Toxicity in Astrocytic/Ventral Mesencephalic Co‐Cultures , 1999, Journal of neurochemistry.

[13]  M. Takahashi,et al.  Hydroxyl radical formation following methamphetamine administration to rats. , 1999, Pharmacology & toxicology.

[14]  F. Cheng,et al.  Inhibitors of Mitochondrial Respiration, Iron (II), and Hydroxyl Radical Evoke Release and Extracellular Hydrolysis of Glutathione in Rat Striatum and Substantia Nigra , 1999, Journal of neurochemistry.

[15]  S. Berman,et al.  Dopamine Oxidation Alters Mitochondrial Respiration and Induces Permeability Transition in Brain Mitochondria , 1999, Journal of neurochemistry.

[16]  W. Slikker,et al.  Methamphetamine generates peroxynitrite and produces dopaminergic neurotoxicity in mice: protective effects of peroxynitrite decomposition catalyst , 1999, Brain Research.

[17]  J. Cano,et al.  The Non‐NMDA Glutamate Receptor Antagonists 6‐Cyano‐7‐Nitroquinoxaline‐2,3‐dione and 2,3‐Dihydroxy‐6‐Nitro‐7‐Sulfamoylbenzo(f)quinoxaline, but Not NMDA Antagonists, Block the Intrastriatal Neurotoxic Effect of MPP+ , 1999, Journal of neurochemistry.

[18]  S. Snyder,et al.  Neuronal Nitric Oxide Synthase Activation and Peroxynitrite Formation in Ischemic Stroke Linked to Neural Damage , 1999, The Journal of Neuroscience.

[19]  C. Rice-Evans,et al.  Inhibition of Peroxynitrite‐Mediated Oxidation of Dopamine by Flavonoid and Phenolic Antioxidants and Their Structural Relationships , 1999, Journal of neurochemistry.

[20]  Jin-Moo Lee,et al.  The changing landscape of ischaemic brain injury mechanisms , 1999, Nature.

[21]  Y. Shinohara,et al.  7-Nitroindazole attenuates nitrotyrosine formation in the early phase of cerebral ischemia-reperfusion in mice , 1999, Neuroscience Letters.

[22]  G. Dryhurst,et al.  Tryptamine-4,5-dione, a putative endotoxic metabolite of the superoxide-mediated oxidation of serotonin, is a mitochondrial toxin: possible implications in neurodegenerative brain disorders. , 1999, Chemical research in toxicology.

[23]  R. Gainetdinov,et al.  Increased Methamphetamine Neurotoxicity in Heterozygous Vesicular Monoamine Transporter 2 Knock-Out Mice , 1999, The Journal of Neuroscience.

[24]  M. Beal,et al.  Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase , 1999, Brain Research.

[25]  S. Sensi,et al.  Preferential Zn2+ influx through Ca2+-permeable AMPA/kainate channels triggers prolonged mitochondrial superoxide production. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. LaVoie,et al.  Dopamine Quinone Formation and Protein Modification Associated with the Striatal Neurotoxicity of Methamphetamine: Evidence against a Role for Extracellular Dopamine , 1999, The Journal of Neuroscience.

[27]  Erwan Bezard,et al.  Absence of MPTP-Induced Neuronal Death in Mice Lacking the Dopamine Transporter , 1999, Experimental Neurology.

[28]  R. Dringen,et al.  Synthesis of the Antioxidant Glutathione in Neurons: Supply by Astrocytes of CysGly as Precursor for Neuronal Glutathione , 1999, The Journal of Neuroscience.

[29]  S. Weber,et al.  Net efflux of cysteine, glutathione and related metabolites from rat hippocampal slices during oxygen/glucose deprivation: dependence on γ-glutamyl transpeptidase , 1999, Brain Research.

[30]  K. Vrana,et al.  Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase , 1998, Journal of neuroscience research.

[31]  G. Zeevalk,et al.  Origins of the Extracellular Glutamate Released During Total Metabolic Blockade in the Immature Retina , 1998, Journal of neurochemistry.

[32]  A. Lees,et al.  Conjugates of Catecholamines with Cysteine and GSH in Parkinson's Disease: Possible Mechanisms of Formation Involving Reactive Oxygen Species , 1998, Journal of neurochemistry.

[33]  H. Li,et al.  Brain Mitochondria Catalyze the Oxidation of 7‐(2‐Aminoethyl)‐3,4‐Dihydro‐5‐Hydroxy‐2H‐1,4‐Benzothiazine‐3‐Carboxylic Acid (DHBT‐1) to Intermediates that Irreversibly Inhibit Complex I and Scavenge Glutathione: Potential Relevance to the Pathogenesis of Parkinson's Disease , 1998, Journal of neurochemistry.

[34]  S. Kish,et al.  Rat striatal levels of the antioxidant glutathione are decreased following binge administration of methamphetamine , 1998, Neuroscience Letters.

[35]  B. Yamamoto,et al.  The effects of methamphetamine on the production of free radicals and oxidative stress. , 1998, The Journal of pharmacology and experimental therapeutics.

[36]  M. Beal,et al.  Manganese Superoxide Dismutase Overexpression Attenuates MPTP Toxicity , 1998, Neurobiology of Disease.

[37]  W. Le,et al.  Antibodies from patients with Parkinson's disease react with protein modified by dopamine oxidation , 1998, Journal of neuroscience research.

[38]  R. Gainetdinov,et al.  Role of Dopamine Transporter in Methamphetamine-Induced Neurotoxicity: Evidence from Mice Lacking the Transporter , 1998, The Journal of Neuroscience.

[39]  S. Przedborski,et al.  Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[40]  G. Dryhurst,et al.  Oxidation of serotonin by superoxide radical: implications to neurodegenerative brain disorders. , 1998, Chemical research in toxicology.

[41]  A. Levey,et al.  Increased MPTP Neurotoxicity in Vesicular Monoamine Transporter 2 Heterozygote Knockout Mice , 1998, Journal of neurochemistry.

[42]  Syed F. Ali,et al.  Effects of 7‐Nitroindazole, an NOS Inhibitor on Methamphetamine‐Induced Dopaminergic and Serotonergic Neurotoxicity in Mice a , 1998, Annals of the New York Academy of Sciences.

[43]  A. Mclean,et al.  The Aging Liver , 1998, Clinical pharmacokinetics.

[44]  D. Perl,et al.  Protein Nitration in Parkinson's Disease , 1998, Journal of neuropathology and experimental neurology.

[45]  J. B. Hutchins,et al.  Mitochondrial Manganese Superoxide Dismutase Prevents Neural Apoptosis and Reduces Ischemic Brain Injury: Suppression of Peroxynitrite Production, Lipid Peroxidation, and Mitochondrial Dysfunction , 1998, The Journal of Neuroscience.

[46]  S. Liljequist,et al.  Metabolic inhibition potentiates AMPA-induced Ca2+ fluxes and neurotoxicity in rat cerebellar granule cells , 1998, Brain Research.

[47]  Y. Mizuno,et al.  Association between the gene encoding the E2 subunit of the α‐ketoglutarate dehydrogenase complex and Parkinson's disease , 1998, Annals of neurology.

[48]  G. Ricaurte,et al.  Effects of 2‐Deoxy‐d‐Glucose on Methamphetamine‐Induced Dopamine and Serotonin Neurotoxicity , 1998, Journal of neurochemistry.

[49]  B. Hyman,et al.  MPP+Induced Substantia Nigra Degeneration Is Attenuated in nNOS Knockout Mice , 1997, Neurobiology of Disease.

[50]  J. Prince,et al.  Normalization of cytochrome-c oxidase activity in the rat brain by neuroleptics after chronic treatment with PCP or methamphetamine , 1997, Neuropharmacology.

[51]  J. Imlay,et al.  Inactivation of Dehydratase [4Fe-4S] Clusters and Disruption of Iron Homeostasis upon Cell Exposure to Peroxynitrite* , 1997, The Journal of Biological Chemistry.

[52]  J. Langston,et al.  MPTP: A Dopaminergic Neurotoxin , 1997 .

[53]  P. R. Gardner,et al.  Nitric Oxide Sensitivity of the Aconitases* , 1997, The Journal of Biological Chemistry.

[54]  G. Dryhurst,et al.  Irreversible Inhibition of Mitochondrial Complex I by 7‐(2‐Aminoethyl)‐3,4‐Dihydro‐5‐Hydroxy‐2H‐1,4‐Benzothiazine‐3‐Carboxylic Acid (DHBT‐1): A Putative Nigral Endotoxin of Relevance to Parkinson's Disease , 1997, Journal of neurochemistry.

[55]  J. Bennett,et al.  Mitochondrial toxins in models of neurodegenerative diseases. I: in vivo brain hydroxyl radical production during sytemic MPTP treatment or following microdialysis infusion of methylpyridinium or azide ions , 1997, Brain Research.

[56]  J. Cano,et al.  Lack of involvement of glutamate‐induced excitotoxicity in MPP+ toxicity in striatal dopaminergic terminals: possible involvement of ascorbate , 1997, British journal of pharmacology.

[57]  R. Kennedy,et al.  In vivo monitoring of glutathione and cysteine in rat caudate nucleus using microdialysis on-line with capillary zone electrophoresis-laser induced fluorescence detection , 1997, Journal of Neuroscience Methods.

[58]  G. Hanson,et al.  Methamphetamine-induced decrease in tryptophan hydroxylase activity: role of 5-hydroxytryptaminergic transporters. , 1997, European journal of pharmacology.

[59]  N. Wood.  Genes and parkinsonism. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[60]  T. Warner,et al.  Mitochondrial Dysfunction in Neurodegeneration , 1997, Journal of bioenergetics and biomembranes.

[61]  H. Hagberg,et al.  Brain injury after hypoxia-ischemia in newborn rats: relationship to extracellular levels of excitatory amino acids and cysteine , 1997, Brain Research.

[62]  P. Steendijk,et al.  Oxidative Stress during Post-Hypoxic-Ischemic Reperfusion in the Newborn Lamb: The Effect of Nitric Oxide Synthesis Inhibition , 1997, Pediatric Research.

[63]  M. Boyd,et al.  Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice , 1997, Brain Research.

[64]  R. Radi,et al.  Pathways of peroxynitrite oxidation of thiol groups. , 1997, The Biochemical journal.

[65]  J. Cano,et al.  Neuroprotective Effect of the Iron Chelator Desferrioxamine Against MPP+ Toxicity on Striatal Dopaminergic Terminals , 1997, Journal of neurochemistry.

[66]  J. Cano,et al.  Less induced 1-methyl-4-phenylpyridinium ion neurotoxicity on striatal slices from guinea-pigs fed with a vitamin C-deficient diet , 1997, Neuroscience.

[67]  K. Matsubara,et al.  Differences in dopamine efflux induced by MPP+ and beta-carbolinium in the striatum of conscious rats. , 1996, European journal of pharmacology.

[68]  E. Hall,et al.  Treatment of mice with methamphetamine produces cell loss in the substantia nigra , 1996, Brain Research.

[69]  R. Swerdlow,et al.  Origin and functional consequences of the complex I defect in Parkinson's disease , 1996, Annals of neurology.

[70]  C. Vorhees,et al.  Effect of methamphetamine on glutamate‐positive neurons in the adult and developing rat somatosensory cortex , 1996, Synapse.

[71]  G. Dryhurst,et al.  Further insights into the influence of L-cysteine on the oxidation chemistry of dopamine: reaction pathways of potential relevance to Parkinson's disease. , 1996, Chemical research in toxicology.

[72]  G. Dryhurst,et al.  Oxidation chemistry of (-)-norepinephrine in the presence of L-cysteine. , 1996, Journal of medicinal chemistry.

[73]  D. S. Albers,et al.  Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP , 1996, Brain Research.

[74]  Annette M. Schmid,et al.  Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones , 1996, Neuroreport.

[75]  J. Schulz,et al.  Role of nitric oxide in neurodegenerative diseases. , 1995, Current opinion in neurology.

[76]  J. Kuo,et al.  Lowered brain glutathione by diethylmaleate decreased the glutamate release induced by cerebral ischemia in anesthetized rats , 1995, Brain Research.

[77]  J. Madl,et al.  Hyperthermia depletes adenosine triphosphate and decreases glutamate uptake in rat hippocampal slices , 1995, Neuroscience.

[78]  E. Lancelot,et al.  Detection of hydroxyl radicals in rat striatum during transient focal cerebral ischemia: possible implication in tissue damage , 1995, Neuroscience Letters.

[79]  N. Sims,et al.  Biochemical changes associated with selective neuronal death following short-term cerebral ischaemia. , 1995, The international journal of biochemistry & cell biology.

[80]  D. J. Reed,et al.  Influence of metabolic inhibitors on mitochondrial permeability transition and glutathione status. , 1995, Biochimica et biophysica acta.

[81]  J. Greene,et al.  Exacerbation of NMDA, AMPA, and l‐Glutamate Excitotoxicity by the Succinate Dehydrogenase Inhibitor Malonate , 1995, Journal of neurochemistry.

[82]  S. Hirai,et al.  Activated microglia cause superoxide-mediated release of iron from ferritin , 1995, Neuroscience Letters.

[83]  C. Epstein,et al.  Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals , 1995, Brain Research.

[84]  M. Zigmond,et al.  Estimating Hydroxyl Radical Content in Rat Brain Using Systemic and Intraventricular Salicylate: Impact of Methamphetamine , 1995, Journal of neurochemistry.

[85]  J. Bennett,et al.  Reduction of MPP(+)-induced hydroxyl radical formation and nigrostriatal MPTP toxicity by inhibiting nitric oxide synthase. , 1994, Neuroreport.

[86]  P. Sonsalla,et al.  Protection against methamphetamine-induced neurotoxicity to neostriatal dopaminergic neurons by adenosine receptor activation. , 1994, The Journal of pharmacology and experimental therapeutics.

[87]  D. Murphy,et al.  In Vivo Generation of Hydroxyl Radicals and MPTP‐Induced Dopaminergic Toxicity in the Basal Ganglia , 1994, Annals of the New York Academy of Sciences.

[88]  J. Gutteridge.  Hydroxyl Radicals, Iron, Oxidative Stress, and Neurodegeneration a , 1994, Annals of the New York Academy of Sciences.

[89]  S. Daniel,et al.  Glutathione‐related enzymes in brain in Parkinson's disease , 1994, Annals of neurology.

[90]  P. Sonsalla,et al.  Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 2: Central administration of 1-methyl-4-phenylpyridinium. , 1994, The Journal of pharmacology and experimental therapeutics.

[91]  C. Marsden,et al.  Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia , 1994, Annals of neurology.

[92]  A. Meister,et al.  Interaction of gamma-glutamyl transpeptidase with acivicin. , 1994, The Journal of biological chemistry.

[93]  B. Yamamoto,et al.  Methamphetamine‐induced neurotoxicity: Roles for glutamate and dopamine efflux , 1994, Synapse.

[94]  J. Langston,et al.  Rapid ATP Loss Caused by Methamphetamine in the Mouse Striatum: Relationship Between Energy Impairment and Dopaminergic Neurotoxicity , 1994, Journal of neurochemistry.

[95]  C. Palmer,et al.  Deferoxamine Posttreatment Reduces Ischemic Brain Injury in Neonatal Rats , 1994, Stroke.

[96]  W. Koppenol,et al.  On the pH-dependent yield of hydroxyl radical products from peroxynitrite. , 1994, Free radical biology & medicine.

[97]  N. Hattori,et al.  An immunohistochemical study on α‐ketoglutarate dehydrogenase complex in Parkinson's disease , 1994 .

[98]  C. Epstein,et al.  Rapid Communication: Attenuation of Methamphetamine‐Induced Neurotoxicity in Copper/Zinc Superoxide Dismutase Transgenic Mice , 1994, Journal of neurochemistry.

[99]  C. Marsden,et al.  Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease , 1994, Annals of neurology.

[100]  Jun Chen,et al.  Human Copper‐Zinc Superoxide Dismutase Transgenic Mice Are Highly Resistant to Reperfusion Injury After Focal Cerebral Ischemia , 1994, Stroke.

[101]  G. Dryhurst,et al.  7-S-glutathionyl-tryptamine-4,5-dione: a possible aberrant metabolite of serotonin. , 1993, Biochemical pharmacology.

[102]  K. Miura,et al.  Maintenance of Neuronal Glutathione by Glial Cells , 1993, Journal of neurochemistry.

[103]  R. Edwards.  Neural degeneration and the transport of neurotransmitters , 1993, Annals of neurology.

[104]  K. Miura,et al.  Cystine Uptake and Glutathione Level in Fetal Brain Cells in Primary Culture and in Suspension , 1993, Journal of neurochemistry.

[105]  D. Flint,et al.  The inactivation of Fe-S cluster containing hydro-lyases by superoxide. , 1993, The Journal of biological chemistry.

[106]  J. Bockaert,et al.  NMDA-dependent superoxide production and neurotoxicity , 1993, Nature.

[107]  A. Iwai,et al.  Protective actions of YM737, a new glutathione analog, against cerebral ischemia in rats. , 1993, Research communications in chemical pathology and pharmacology.

[108]  J. O. Schenk,et al.  D2 Receptors May Modulate the Function of the Striatal Transporter for Dopamine: Kinetic Evidence from Studies In Vitro and In Vivo , 1993, Journal of neurochemistry.

[109]  B. Hyman,et al.  Blockade of 1-methyl-4-phenylpyridinium ion (MPP+) nigral toxicity in the rat by prior decortication or MK-801 treatment: A stereological estimate of neuronal loss , 1993, Neurobiology of Aging.

[110]  J. B. Justice,et al.  Quantitative microdialysis under transient conditions. , 1993, Analytical chemistry.

[111]  A. Slivka,et al.  Brain ischemia markedly elevates levels of the neurotoxic amino acid, cysteine , 1993, Brain Research.

[112]  R. Busto,et al.  Ischemia‐Induced Extracellular Release of Serotonin Plays a Role in CA1 Neuronal Cell Death in Rats , 1992, Stroke.

[113]  C. W. Olanow,et al.  Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study , 1992, Brain Research.

[114]  M. Cuénod,et al.  Screening of Thiol Compounds: Depolarization‐Induced Release of Glutathione and Cysteine from Rat Brain Slices , 1992, Journal of neurochemistry.

[115]  B. Yamamoto,et al.  Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3, 4-methylenedioxymethamphetamine , 1992, Brain Research.

[116]  D. D. Di Monte,et al.  Mitochondrial poisons cause depletion of reduced glutathione in isolated hepatocytes. , 1992, Archives of biochemistry and biophysics.

[117]  E. Azmitia,et al.  The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine. , 1992, European journal of pharmacology.

[118]  C. Epstein,et al.  Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[119]  B. Rosen,et al.  1‐Methyl‐4‐Phenylpyridinium Produces Excitotoxic Lesions in Rat Striatum as a Result of Impairment of Oxidative Metabolism , 1992, Journal of neurochemistry.

[120]  H. Przuntek,et al.  MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease. , 1991, European journal of pharmacology.

[121]  M. Molliver,et al.  Immunocytochemical evidence for methamphetamine‐induced serotonergic axon loss in the rat brain , 1991, Synapse.

[122]  S. O'dell,et al.  Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity , 1991, Brain Research.

[123]  C. Chiueh,et al.  MPP+ Enhances Potassium‐Evoked Striatal Dopamine Release through a ω‐ConOtoxin‐Insensitive, Tetrodotoxin‐ and Nimodipine‐ Sensitive Calcium‐Dependent Mechanism , 1991, Annals of the New York Academy of Sciences.

[124]  J. Sanchez-Ramos,et al.  Selective and Nonselective Effects of 1‐Methyl‐4‐ Phenylpyridinium on Oxygen Consumption in Rat Striatal and Hippocampal Slices , 1991, Journal of neurochemistry.

[125]  J. Langston,et al.  Rapid ATP Loss Caused by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine in Mouse Brain , 1991, Journal of neurochemistry.

[126]  N. Sims.  Selective Impairment of Respiration in Mitochondria Isolated from Brain Subregions Following Transient Forebrain Ischemia in the Rat , 1991, Journal of neurochemistry.

[127]  J. Rubins,et al.  Modification of Brain Guanine Nucleotide‐Binding Regulatory Proteins by Tryptamine‐4,5‐Dione, a Neurotoxic Derivative of Serotonin , 1991, Journal of neurochemistry.

[128]  G. Zeevalk,et al.  Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition. , 1991, The Journal of pharmacology and experimental therapeutics.

[129]  C. Marsden,et al.  Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's Disease , 1990, Journal of neurochemistry.

[130]  D. D. Di Monte,et al.  Relationships between the mitochondrial transmembrane potential, ATP concentration, and cytotoxicity in isolated rat hepatocytes. , 1990, Archives of biochemistry and biophysics.

[131]  Z. Rossetti,et al.  The non-competitive NMDA-receptor antagonist MK-801 prevents the massive release of glutamate and aspartate from rat striatum induced by 1-methyl-4-phenylpyridinium (MPP+) , 1990, Neuroscience Letters.

[132]  K. Kogure,et al.  Role of the excitotoxic mechanism in the development of neuronal damage following repeated brief cerebral ischemia in the gerbil: protective effects of MK-801 and pentobarbital , 1990, Brain Research.

[133]  J. Olney,et al.  L-cysteine, a bicarbonate-sensitive endogenous excitotoxin. , 1990, Science.

[134]  R. Myers,et al.  Delayed Onset of Neurologic Deterioration following Anoxia/Ischemia Coincides with Appearance of Impaired Brain Mitochondrial Respiration and Decreased Cytochrome Oxidase Activity , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[135]  G. Marek,et al.  Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons , 1990, Brain Research.

[136]  A. Harken,et al.  Iron depletion or chelation reduces ischemia/reperfusion-induced edema in gerbil brains. , 1990, Journal of pediatric surgery.

[137]  B. Vogt,et al.  Neurotoxic effects of partially oxidized serotonin: tryptamine-4,5-dione , 1989, Brain Research.

[138]  R. Busto,et al.  Direct Evidence for Acute and Massive Norepinephrine Release in the Hippocampus during Transient Ischemia , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[139]  C. Marsden,et al.  A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra , 1989, Journal of neurochemistry.

[140]  J. Lai,et al.  Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons , 1989, Brain Research.

[141]  P. Crino,et al.  Increased serotonin efflux by a partially oxidized serotonin: tryptamine-4,5-dione. , 1989, The Journal of pharmacology and experimental therapeutics.

[142]  G. Hanson,et al.  Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog. , 1989, European journal of pharmacology.

[143]  G. Hanson,et al.  Acute inactivation of tryptophan hydroxylase by amphetamine analogs involves the oxidation of sulfhydryl sites. , 1989, European journal of pharmacology.

[144]  W. Nicklas,et al.  Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. , 1989, Science.

[145]  K. Abe,et al.  Extracellular accumulation of glutamate in the hippocampus induced by ischemia is not calcium dependent — In vitro and in vivo evidence , 1989, Neuroscience Letters.

[146]  R. Busto,et al.  Intra-ischemic extracellular release of dopamine and glutamate is associated with striatal vulnerability to ischemia , 1988, Neuroscience Letters.

[147]  A. Novelli,et al.  Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced , 1988, Brain Research.

[148]  A. Foster,et al.  MK-801 is neuroprotective in gerbils when administered during the post-ischaemic period , 1988, Neuroscience.

[149]  J. Olney,et al.  Excitatory Amino Acid Receptor Potency and Subclass Specificity of Sulfur‐Containing Amino Acids , 1987, Journal of neurochemistry.

[150]  J. Langston,et al.  Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+ , 1987, Neuroscience Letters.

[151]  Y. Mizuno,et al.  Inhibition of mitochondrial alpha-ketoglutarate dehydrogenase by 1-methyl-4-phenylpyridinium ion. , 1987, Biochemical and biophysical research communications.

[152]  L. Steranka,et al.  Effect of cysteine on the persistent depletion of brain monoamines by amphetamine, p-chloroamphetamine and MPTP. , 1987, European journal of pharmacology.

[153]  C. J. Schmidt,et al.  Ascorbic acid-deficient condition alters central effects of methamphetamine , 1987, Brain Research.

[154]  R. Fariello,et al.  Effect of 1-methyl-4-phemyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutathione in the extrapyramidal system of the mouse , 1986, Neuropharmacology.

[155]  G. Hanson,et al.  Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems. , 1986, The Journal of pharmacology and experimental therapeutics.

[156]  R. Ramsay,et al.  Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP. , 1986, Life sciences.

[157]  B. Westerink,et al.  Brain dialysis in conscious rats reveals an instantaneous massive release of striatal dopamine in response to MPP+. , 1986, European journal of pharmacology.

[158]  V. Yong,et al.  Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment , 1986, Neuroscience Letters.

[159]  B. Winblad,et al.  Transmitter deficits in Alzheimer's disease , 1985, Neurochemistry International.

[160]  W. Matson,et al.  Serotoninergic system in dementia of the Alzheimer type. Abnormal forms of 5-hydroxytryptophan and serotonin in cerebrospinal fluid. , 1985, Archives of neurology.

[161]  S. Snyder,et al.  Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[162]  H. Benveniste,et al.  Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis , 1984, Journal of neurochemistry.

[163]  L. Nowak,et al.  Magnesium gates glutamate-activated channels in mouse central neurones , 1984, Nature.

[164]  H. Sies,et al.  Oxidation of glutathione by the superoxide radical to the disulfide and the sulfonate yielding singlet oxygen. , 1983, European journal of biochemistry.

[165]  J. Weinberger,et al.  Nerve terminal damage in cerebral ischemia: greater susceptibility of catecholamine nerve terminals relative to serotonin nerve terminals. , 1983, Stroke.

[166]  L. Seiden,et al.  Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine , 1983, Neuropharmacology.

[167]  W. Pulsinelli,et al.  Regional Energy Balance in Rat Brain After Transient Forebrain Ischemia , 1983, Journal of neurochemistry.

[168]  Arthur J. L. Cooper,et al.  Glutathione and Ascorbate During Ischemia and Postischemic Reperfusion in Rat Brain , 1980, Journal of neurochemistry.

[169]  J. Gibb,et al.  Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. , 1980, The Journal of pharmacology and experimental therapeutics.

[170]  L. Seiden,et al.  Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study , 1980, Brain Research.

[171]  S. Rehncrona,et al.  Influence of Complete and Pronounced Incomplete Cerebral Ischemia and Subsequent Recirculation on Cortical Concentrations of Oxidized and Reduced Glutathione in the Rat , 1980, Journal of neurochemistry.

[172]  M. Raiteri,et al.  Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. , 1979, The Journal of pharmacology and experimental therapeutics.

[173]  G. Cohen,et al.  Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices. , 1975, Biochemical pharmacology.

[174]  N. Andén,et al.  A quantitative study on the nigro-neostriatal dopamine neuron system in the rat. , 1966, Acta physiologica Scandinavica.

[175]  N. Sims,et al.  Ischemia in Rats , 2002 .

[176]  H. Li,et al.  Oxidative metabolites of 5-S-cysteinyldopamine inhibit the α-ketoglutarate dehydrogenase complex: possible relevance to the pathogenesis of Parkinson's disease , 2000, Journal of Neural Transmission.

[177]  P. Jenner,et al.  Neuronal nitric oxide synthase inhibition reduces MPP+-evoked hydroxyl radical formation but not dopamine efflux in rat striatum , 1999, Journal of Neural Transmission.

[178]  L. Seiden,et al.  Evidence for and Mechanism of Action of Neurotoxicity of Amphetamine Related Compounds , 1998 .

[179]  L. Matsuda,et al.  Neurotoxicity of amphetamines and their metabolites. , 1997, NIDA research monograph.

[180]  J. Kuo,et al.  In vivo evidence of hydroxyl radical formation induced by elevation of extracellular glutamate after cerebral ischemia in the cortex of anesthetized rats. , 1996, Free radical biology & medicine.

[181]  W. H. Porter,et al.  Hydroxyl radical generation in rat brain is initiated by iron but not aluminum, as determined by microdialysis with salicylate trapping and GC-MS analysis. , 1995, Neurotoxicology.

[182]  M. Beal.  Mitochondrial dysfunction and oxidative damage in neurodegenerative diseases , 1995 .

[183]  D. Segal,et al.  Amphetamine and its analogs : psychopharmacology, toxicology, and abuse , 1994 .

[184]  K. Lange,et al.  MPTP-induced degeneration: interference with glutamatergic toxicity. , 1994, Journal of neural transmission. Supplementum.

[185]  T. Oishi,et al.  Sulfhydryl drugs reduce neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridime (MPTP) in the mouse , 1993, Journal of neural transmission. Parkinson's disease and dementia section.

[186]  A. Eldefrawi,et al.  ATP-regulated neuronal catecholamine uptake: a new mechanism. , 1990, Life sciences.

[187]  A. Carlsson,et al.  The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra , 1989, Journal of neural transmission. Parkinson's disease and dementia section.

[188]  J. Clemens,et al.  Dopamine depletion protects striatal neurons from ischemia-induced cell death. , 1988, Life sciences.

[189]  H. L. Wiener,et al.  (-)-2-Oxo-4-thiazolidine carboxylic acid attenuates 1-methyl-4-phenyl-1,1,2,3,6-tetrahydropyridine induced neurotoxicity , 1988 .

[190]  S J Kish,et al.  Biochemical pathophysiology of Parkinson's disease. , 1987, Advances in neurology.

[191]  A. Meister,et al.  [50] γ-Glutamyl transpeptidase from kidney , 1985 .

[192]  A. Meister,et al.  [47] Glutathione biosynthesis; γ-glutamylcysteine synthetase from rat kidney , 1985 .